Share. Connect. Create. Grow. · Socialiya
Novo Nordisk Shares Drop After Drug Candidate Fails in Trial

Results of two additional trials testing ziltivekimab are expected in the first half of next year.

BUSINESS NEWS July 31, 2026

Novo Nordisk Shares Drop After Drug Candidate Fails in Trial

Results of two additional trials testing ziltivekimab are expected in the first half of next year.

9 views 0 likes 0 comments
Share:
Results of two additional trials testing ziltivekimab are expected in the first half of next year.

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya